Guggenheim analyst Sandy Draper maintains The Oncology Institute (NASDAQ:TOI) with a Buy and lowers the price target from $7 to $6.
Guggenheim Maintains Buy on The Oncology Institute, Lowers Price Target to $6
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.